Yongquan Tian
Overview
Explore the profile of Yongquan Tian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
879
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tan H, Zhu G, She L, Wei M, Wang Y, Pi L, et al.
Am J Cancer Res
. 2018 Jan;
7(12):2554-2565.
PMID: 29312808
Purpose: MicroRNAs function through regulating specific target mRNA expression and then participate in the development and progression of diverse human cancers. MiR-98 shows aberrant expression and dysfunction in tumors. However,...
12.
Huang D, Qiu Y, Li G, Liu C, She L, Zhang D, et al.
J Cancer
. 2018 Jan;
9(1):198-204.
PMID: 29290786
Lysine demethylase (KDM) 5B, as a member of the histone lysine demethylase family, is overexpressed and functions abnormally in various human cancers. However, its expression in the squamous cell carcinoma...
13.
Pi L, Zhu G, She L, Wei M, Liu G, Chen C, et al.
J Cancer
. 2017 Aug;
8(12):2336-2345.
PMID: 28819438
Derlin-1 is over-expressed to function as an oncoprotein in breast, lung and colon cancers. However, the implications of Derlin-1 involved in squamous cell carcinoma of the head and neck (SCCHN)...
14.
Su Z, Li G, Liu C, Ren S, Deng T, Zhang S, et al.
Oncol Lett
. 2017 Jun;
13(6):4147-4154.
PMID: 28599416
Drug resistance restricts the efficacy of cisplatin in the treatment of nasopharyngeal carcinoma (NPC). Increasing evidence indicates that autophagy and the epithelial-mesenchymal transition (EMT) participate in cancer progression and drug...
15.
Liu C, Li G, Ren S, Su Z, Wang Y, Tian Y, et al.
Oncol Lett
. 2017 Apr;
13(4):2631-2636.
PMID: 28454443
MicroRNAs (miRs) have been recognised as important regulators of malignant behaviour in different types of human cancer, including nasopharyngeal carcinoma (NPC). A previous study by our group revealed that miR-185-3p...
16.
Liu C, Li G, Yang N, Su Z, Zhang S, Deng T, et al.
Cancer Cell Int
. 2017 Jan;
17:2.
PMID: 28053597
Background: Nasopharyngeal carcinoma (NPC) is a malignant epithelial carcinoma of the head and neck with strong ability of invasion and metastasis. Our previous study indicated that miR-324-3p, as a tumor-suppressive...
17.
Li G, Liu Y, Liu C, Su Z, Ren S, Wang Y, et al.
BMC Cancer
. 2016 Sep;
16:719.
PMID: 27599611
Background: Radioresistance is one of the major factors limiting the therapeutic efficacy and prognosis of patients with nasopharyngeal carcinoma (NPC). Accumulating evidence has suggested that aberrant expression of long noncoding...
18.
Ren S, Li G, Liu C, Cai T, Su Z, Wei M, et al.
Oncol Rep
. 2016 Aug;
36(4):1861-7.
PMID: 27498905
Paclitaxel chemoresistance restricts the therapeutic efficacy and prognosis of patients with nasopharyngeal carcinoma (NPC). Accumulating evidence suggests that aberrant expression of long non-coding RNAs (lncRNAs) contributes to cancer progression. Therefore,...
19.
Su Z, Li G, Liu C, Ren S, Tian Y, Liu Y, et al.
Oncol Rep
. 2016 Apr;
36(1):72-8.
PMID: 27108809
Post-irradiation residual mass and recurrence always suggest a worse prognosis for nasopharyngeal carcinoma (NPC). Our study aimed to investigate the malignant behaviors of post-irradiation residual NPC cells, to identify the...
20.
Liu W, Tian Y, Zheng Z, Cao Q
Zhonghua Yi Xue Za Zhi
. 2016 Jan;
95(40):3302-4.
PMID: 26815353
Objective: To study the status of hospital infection management staff of the Inner Mongolia Autonomous Region. Methods: The respondents completed the unified questionnaire. The person entered into the computer after...